Reagents and Consumables
ID: NIH-CC-OPC-25-000032Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

DRUGS AND BIOLOGICALS (6505)
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract for reagents and consumables to STEMCELL Technologies Inc. for use with the RoboSep™-S Cell Separator Systems at the NIH Clinical Center in Bethesda, Maryland. The procurement includes specific items such as the EasySep HLA Chimerism WB Myeloid Positive Selection kit, the EasySep HLA Chimerism WB CD3 Positive Selection kit, and RoboSep Filter Tip Racks, which are critical for separating cell populations in allogeneic transplant patients to assess engraftment status. Interested vendors capable of providing equivalent products may submit a capability statement by the specified deadline, with inquiries directed to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov. The acquisition falls under NAICS code 325414, and the total purchase order will not exceed the simplified acquisition threshold.

    Point(s) of Contact
    Files
    Title
    Posted
    The document outlines a procurement list under the federal government supply request, specifically item number 25-000032. It details three items required for laboratory utilization in a biomedical context: the EasySep HLA Chimerism WB Myeloid Positive Selection kit and the EasySep HLA Chimerism WB CD3 Positive Selection kit, both with an estimated quantity of 20 each, and RoboSep Filter Tip Racks, totaling 200 units. The organization aims to meet specific supply needs through this request, indicating their focus on high-quality laboratory processes essential for clinical or research applications. The summarized list conveys essential information required for potential vendors interested in fulfilling these supply orders.
    Lifecycle
    Title
    Type
    Reagents and Consumables
    Currently viewing
    Presolicitation
    Similar Opportunities
    Reagents and Consumables
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is planning to award a Firm-Fixed price purchase order for various reagents and consumables necessary for clinical patient care testing at the NIH Clinical Center. The procurement is intended to secure proprietary products from Life Technologies Corporation, which are essential for diagnosing and monitoring hematological disorders, ensuring compliance with regulatory standards, and maintaining the integrity of laboratory operations. Interested vendors capable of providing equivalent products are invited to submit capability statements by the specified deadline, with inquiries directed to Kimala Winfield at kimala.winfield@nih.gov or Malinda Dehner at dehnerm@cc.nih.gov. The acquisition will adhere to the simplified acquisition threshold and is being conducted under FAR Subpart 13.106-1(b)(i) for sole source procurement.
    Therakos Cellex Photopheresis System Procedural Kits for the Department of Transfusion Medicine
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a firm-fixed price contract for the procurement of five cases of Therakos Cellex USA Kits, essential for emergent Extracorporeal Photopheresis (ECP) procedures at the NIH Clinical Center in Bethesda, Maryland. These procedural kits are critical for patient care, particularly for those undergoing post-stem-cell transplant treatments, as they are the only compatible kits for the THERAKOS® CELLEX® Photopheresis System Instrument. Interested parties capable of providing similar products are encouraged to submit a capability statement by October 20, 2024, at noon EST, to Tasha Lowe at lowet2@mail.nih.gov, as the procurement will follow simplified acquisition procedures exempt from competitive requirements.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Active
    Health And Human Services, Department Of
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.
    Sysmex XN-1000 Automated Hematology Analyzers Preventative Maintenance
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole-source contract to Sysmex American, Inc. for preventative maintenance services of Sysmex XN-1000 Automated Hematology Analyzers at their Bethesda, MD facility. This firm fixed-price contract will cover a base period with the option for four additional years, ensuring the continued operational integrity of these critical diagnostic instruments used for complete blood counts in clinical research and therapy for conditions such as cancer and autoimmune diseases. The acquisition follows simplified acquisition procedures under FAR Part 13, allowing the government to engage a single source when deemed necessary, and interested parties may express their capabilities to the NIH by October 20, 2024, via email to Emeka Onyejekwe at emeka.onyejekwe@nih.gov.
    Illumina, Inc MiSeq Instruments Preventative Maintenance
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source firm fixed-price contract to Illumina, Inc. for the preventative maintenance of MiSeq Sequencing Systems located in Bethesda, Maryland. This contract is crucial for ensuring the operational integrity of the equipment, which is essential for high-resolution Human Leukocyte Antigen (HLA) typing in transplant patient testing. Illumina, Inc. is the sole manufacturer and service provider for these systems, and their maintenance is necessary to prevent warranty invalidation and ensure accurate patient test results. Interested parties may express their interest by October 21, 2024, but the decision to not pursue competitive bids will be at the discretion of the government. For further inquiries, contact Emeka Onyejekwe at emeka.onyejekwe@nih.gov.
    Reagent Generation for Bioanalytical Method Development on Biologics
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified sources for a potential contract focused on reagent generation for bioanalytical method development related to biologics. The primary objective is to obtain information on the availability and capability of companies to generate and deliver reagents, including anti-drug antibodies, that support the quantification of novel biologic drugs in various biological matrices. This initiative is crucial for advancing drug development processes and improving success rates in preclinical stages, with the Therapeutic Development Branch (TDB) at NIH playing a pivotal role in moving therapeutic candidates through the drug development pipeline. Interested parties must submit their capability statements by November 8, 2024, to Nick Niefeld at nick.niefeld@nih.gov, referencing sources sought notice number 75N95025R00007.
    SERVICE AGREEMENT FOR FACSYMPHONY A5 SPECTRAL CELL ANALYZER AND HIGH THROUGHPUT SAMPLER
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking a qualified contractor to provide a service agreement for the BD FACSymphony A5 Spectral Cell Analyzer and High Throughput Sampler. The procurement includes comprehensive coverage for parts, labor, and preventative maintenance, ensuring the operational efficiency of critical laboratory equipment used in research and diagnostics. The contract will be awarded based on technical capability and price, with a performance period from December 13, 2024, to December 12, 2025. Interested vendors must submit their quotes via the NIAID electronic Simplified Acquisition Submission System (eSASS) by October 21, 2024, at 12:00 am EST, and can contact Maliaka Pinkney at maliaka.pinkney@nih.gov for further inquiries.
    Reagent Dispenser
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH), specifically the National Institute of Allergy and Infectious Diseases (NIAID), is seeking information on domestically manufactured reagent dispensers through a Sources Sought notice. The procurement aims to identify U.S.-made products that meet stringent specifications, including features such as custom plate addition, high precision peristaltic pumping, and a dispensing volume capacity ranging from 0.5 to 2500μl, among others. This initiative underscores the importance of domestic manufacturing in scientific and medical instrumentation, aligning with the Buy American Act and Executive Order 14005. Interested vendors must submit their capability statements by October 25, 2024, to Kelly Lowe at kelly.lowe@nih.gov, ensuring compliance with the outlined requirements and confidentiality stipulations.
    Brand Name or Equal: Attana automated sample-robot for Attana Cell 200/250 System
    Active
    Health And Human Services, Department Of
    Sources Sought HEALTH AND HUMAN SERVICES, DEPARTMENT OF NATIONAL INSTITUTES OF HEALTH is seeking a brand name or equal Attana automated sample-robot for Attana Cell 200/250 System. This laboratory equipment and supplies procurement is for the Mass Spectrometry and Epitope Discovery Facility (MSEDF) at the Center for Immuno-Oncology (CIO), Center for Cancer Research (CCR), National Cancer Institute (NCI), National Institutes of Health (NIH). The facility requires an upgraded version of the existing Attana 200 Cell system's automated robot component for sample storage, handling, rinsing, and injection into the Attana 200 Cell system for analysis. The new system must be fully compatible and seamlessly integrate with the existing system, conduct all workflow steps autonomously, produce consistent and repeatable workflows, have a temperature-controlled sample storage unit, and be supported by software compatible with the Attana 200 Cell system. The procurement includes the Attana upgrade: automated sample-robot for Cell 200/250, Attana sample storage, cooled, and Attana software upgrade for new automation. Delivery and installation are required within fourteen (14) calendar days of the purchase order award at Bldg. 10, 10 Center Dr., Bethesda, MD 20892. The contractor must provide one (1) training session for NCI staff at the location of delivery within two (2) business days of equipment installation.
    BD Biosciences BD FACSLyric™ 3L10C Lease, Consumables and Service
    Active
    Health And Human Services, Department Of
    The National Institutes of Health (NIH) is seeking qualified contractors to provide leasing, consumables, and maintenance services for the BD FACSLyric™ 3L10C system, as part of a sources sought announcement. The procurement aims to ensure the continued operation of critical laboratory equipment used for immunology flow cytometry, which is essential for delivering over one million test results annually for patient care and research. This opportunity emphasizes the need for proprietary reagents and robust support from the manufacturer, highlighting the importance of consistent and reliable testing in a clinical research environment. Interested parties must submit their responses by 12:00 PM Eastern Standard Time on October 23, 2024, to the primary contact, Kimala Winfield, at kimala.winfield@nih.gov.